Statistical modeling, optimization and characterization of solid self-nanoemulsifying drug delivery system of lopinavir using design of experiment
- PMID: 26882014
- DOI: 10.3109/10717544.2016.1141260
Statistical modeling, optimization and characterization of solid self-nanoemulsifying drug delivery system of lopinavir using design of experiment
Abstract
Objective: Lopinavir (LPV), an antiretroviral protease inhibitor shows poor bioavailability because of poor aqueous solubility and extensive hepatic first-pass metabolism. The aim of the present work was to investigate the potential of the solid self-nanoemulsifying drug delivery system (S-SNEDDS) in improving dissolution rate and oral bioavailability of LPV.
Materials and methods: Liquid SNEDDS (L-SNEDDS) of LPV were prepared using Capmul MCM C8, Cremophor RH 40 and propylene glycol and their amounts were optimized by Scheffe's mixture design. L-SNEDDS formulations were evaluated for different physicochemical and in vitro drug release parameters. S-SNEDDS were prepared by adsorbing L-SNEDDS on Neusilin US2 and characterized for solid-state properties. In vivo bioavailability of S-SNEDDS, marketed Lopinavir + Ritonavir (LPV/RTV) formulation and pure LPV was studied in Wistar rats. Stability study of S-SNEDDS was performed as per ICH guidelines.
Results and discussion: Optimized L-SNEDDS obtained by Scheffe design had drug loading 160 ± 1.15 mg, globule size 32.9 ± 1.45 nm and drug release >95% within 15 min. Solid state studies suggested the transformation of the crystalline drug to amorphous drug. The size and zeta potential of globules obtained on dilution S-SNEDDS remained similar to L-SNEEDS. In vivo bioavailability study revealed that S-SNEDDS has 2.97 and 1.54-folds higher bioavailability than pure LPV and LPV/RTV formulation, respectively. The optimized S-SNEDDS was found to be stable and had a shelf life of 2.85 years.
Conclusion: The significant increase in drug dissolution and bioavailability by prepared SNEDDS suggest that the developed S-SNEDDS is a useful solid platform for improving oral bioavailability of poorly soluble LPV.
Keywords: Bioavailability; Scheffe design; dissolution; lopinavir; solid carriers; solid self-nanoemulsifying drug delivery system.
Similar articles
-
Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: In vitro and in vivo evaluation.Eur J Pharm Sci. 2015 Jul 10;74:1-10. doi: 10.1016/j.ejps.2015.03.024. Epub 2015 Apr 3. Eur J Pharm Sci. 2015. PMID: 25845633
-
Development and Optimization of Solid Self Nanoemulsifying Drug Delivery (S-SNEDDS) Using D-Optimal Design for Improvement of Oral Bioavailability of Amiodarone Hydrochloride.Curr Drug Deliv. 2015;12(6):745-60. doi: 10.2174/1567201812666150302122501. Curr Drug Deliv. 2015. PMID: 25731867
-
Valsartan Loaded Solid Self-Nanoemulsifying Delivery System to Enhance Oral Absorption and Bioavailability.AAPS PharmSciTech. 2025 Jan 23;26(1):45. doi: 10.1208/s12249-024-03032-0. AAPS PharmSciTech. 2025. PMID: 39849239
-
Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances.Nanomedicine (Lond). 2010 Dec;5(10):1595-616. doi: 10.2217/nnm.10.126. Nanomedicine (Lond). 2010. PMID: 21143036 Review.
-
Potentials and challenges in self-nanoemulsifying drug delivery systems.Expert Opin Drug Deliv. 2012 Oct;9(10):1305-17. doi: 10.1517/17425247.2012.719870. Epub 2012 Sep 6. Expert Opin Drug Deliv. 2012. PMID: 22954323 Review.
Cited by
-
Nanoformulated Eudragit lopinavir and preliminary release of its loaded suppositories.Heliyon. 2020 May 7;6(5):e03890. doi: 10.1016/j.heliyon.2020.e03890. eCollection 2020 May. Heliyon. 2020. PMID: 32420478 Free PMC article.
-
Quality-by-Design-Based Development of a Voxelotor Self-Nanoemulsifying Drug-Delivery System with Improved Biopharmaceutical Attributes.Pharmaceutics. 2021 Sep 2;13(9):1388. doi: 10.3390/pharmaceutics13091388. Pharmaceutics. 2021. PMID: 34575467 Free PMC article.
-
Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics.Biomedicines. 2022 Aug 23;10(9):2055. doi: 10.3390/biomedicines10092055. Biomedicines. 2022. PMID: 36140156 Free PMC article. Review.
-
Self-nanoemulsifying drug delivery system of bruceine D: a new approach for anti-ulcerative colitis.Int J Nanomedicine. 2018 Sep 28;13:5887-5907. doi: 10.2147/IJN.S174146. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30319255 Free PMC article.
-
Pre-Formulation Studies of Lipid-Based Formulation Approach for a Poorly Water-Soluble Biopharmaceutics Classification System Class II Model Drug: Bosentan.Turk J Pharm Sci. 2025 May 14;22(2):140-153. doi: 10.4274/tjps.galenos.2025.48840. Turk J Pharm Sci. 2025. PMID: 40366240 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources